Lumpectomy vs. Mastectomy
I have a choice?
One of the most important decisions you'll make, and you don't have to make it alone. If you've been diagnosed with breast cancer, you are almost certainly facing this question: should I have a lumpectomy or a mastectomy? It is one of the most emotionally and medically significant decisions a person can make and it is one that deserves more than a rushed conversation at the end of a clinic appointment. This guide is designed to help you understand the difference between the two approaches, what the evidence actually says about outcomes, and what questions to bring to your surgical consultation. It is not a substitute for that conversation, but it will make the conversation better.
What Each Procedure Actually Involves
Lumpectomy
A lumpectomy removes the tumor and a surrounding margin of healthy tissue while preserving the rest of the breast. The goal is complete removal of the cancer confirmed by clear margins on pathology while keeping the breast intact. Lumpectomy is almost always followed by radiation therapy to the remaining breast tissue, which significantly reduces the risk of local recurrence.
When performed with oncoplastic techniques, lumpectomy can remove larger tumors than traditional approaches while simultaneously reshaping the breast to minimize deformity, making breast conservation possible for patients who might otherwise be told mastectomy is their only option.
Mastectomy
A mastectomy removes all breast tissue. Depending on the type of mastectomy performed, the skin, nipple, and areola may or may not be preserved. Total mastectomy removes everything. Skin-sparing mastectomy preserves the breast skin envelope. Nipple-sparing mastectomy preserves the skin and nipple-areolar complex where oncologically appropriate — allowing for immediate reconstruction with a significantly better aesthetic result.
Mastectomy does not always require radiation, though it may be recommended depending on tumor characteristics and nodal status.
What The Evidence Says
The most important things patients don't know
Here is what decades of clinical evidence consistently shows: for most early-stage breast cancers, lumpectomy followed by radiation produces equivalent long-term survival rates to mastectomy.
This is not a controversial finding. It is supported by multiple large randomized controlled trials conducted over more than 30 years, and it forms the basis of national treatment guidelines from the National Comprehensive Cancer Network (NCCN) and the American Society of Breast Surgeons.
The belief that removing more breast tissue is inherently safer is one of the most common and consequential misconceptions in breast cancer treatment. For most patients with early-stage disease, it is not true. Mastectomy is not more aggressive in a way that translates to better survival — it is simply a different operation with different implications for the breast.
This does not mean lumpectomy is always the right choice. It means the choice should be driven by your clinical situation and your personal goals — not by a fear that lumpectomy is somehow leaving something behind.
When Each Makes More Sense
The factors that actually drive this decision
Factors that favor lumpectomy
- Early-stage disease (Stage I or II) with a tumor that can be removed with clear margins while preserving meaningful breast volume
- Tumor location and size that allows adequate resection with an acceptable cosmetic result — particularly when oncoplastic techniques are available
- Patient preference for breast conservation
- No genetic mutation (such as BRCA1/2) that significantly elevates lifetime risk in the remaining breast tissue
- No prior radiation to the chest wall that would preclude post-lumpectomy radiation
Factors that favor mastectomy
- Large tumor relative to breast size where adequate resection would leave little meaningful breast tissue
- Multiple tumors in different quadrants of the breast (multifocal or multicentric disease)
- Prior radiation to the chest making further radiation unsafe
- BRCA1 or BRCA2 mutation or other high-risk genetic finding where removing the breast significantly reduces lifetime risk
- Strong personal preference for mastectomy — including for peace of mind — after a thorough understanding of the oncologic equivalence of both approaches
- Inability to commit to the radiation schedule that follows lumpectomy
What about DCIS?
Ductal carcinoma in situ (DCIS) presents its own set of considerations. DCIS is non-invasive and highly treatable, but its management — lumpectomy with radiation versus mastectomy — depends on the extent of DCIS, its grade, and the patient's individual risk factors. The same principle applies: more surgery is not automatically better surgery.
The Emotional Reality
What No One Tells You About This Decision
Many patients feel pressure (subtle or direct) toward mastectomy. Sometimes it comes from well-meaning family members who equate removing more with doing more. Sometimes it comes from a deep, understandable fear of recurrence that makes the idea of keeping the breast feel like a risk. Sometimes it comes from a belief that a surgeon recommending lumpectomy is recommending the easier path.
None of these pressures should drive this decision.
Mastectomy does not eliminate the possibility of recurrence. Cancer can recur after mastectomy in the chest wall, in regional lymph nodes, or distantly. The goal of surgery is not to achieve certainty, which no operation can provide. The goal is to remove the cancer completely with the approach that is right for your clinical situation and your life.
Your feelings about your body, your relationship with your breast, your fear of recurrence, your ability to commit to radiation, your reconstructive goals are all legitimate factors in this decision.
Dr. Palakodeti will ask about them. And he will give you the same honest clinical recommendation regardless of what you walk in hoping to hear.
Questions to Ask Your Surgeon
Bring these questions to your appointment
About your specific diagnosis:
- Based on my tumor size, location, and type — am I a candidate for lumpectomy?
- What are my expected margin outcomes with lumpectomy versus mastectomy for my specific tumor?
- Do I have any features — tumor size, grade, multifocality, genetic risk — that make mastectomy the clinically stronger recommendation for me?
- What is my estimated recurrence risk with lumpectomy and radiation versus mastectomy?
About the surgical approach:
- Are oncoplastic techniques available for my lumpectomy — and would they improve my cosmetic outcome?
- If I choose mastectomy, am I a candidate for nipple-sparing mastectomy?
- What reconstructive options are available to me if I choose mastectomy?
- Can reconstruction be performed at the same time as mastectomy?
About radiation:
- Will I need radiation after lumpectomy?
- Will I need radiation after mastectomy given my tumor characteristics?
- What does the radiation schedule look like — how many sessions, over how many weeks?
About recovery:
- What is the recovery difference between lumpectomy and mastectomy for someone with my situation?
- How will each option affect my appearance and how I feel about my body?
About next steps:
- If I choose lumpectomy and margins are not clear, what happens next?
- How does this surgical decision interact with any planned chemotherapy or hormone therapy?
- What would you recommend for a patient in my exact situation and why?
"I've had patients come in certain they needed a mastectomy who were excellent lumpectomy candidates, and patients who came in hoping to save their breast where mastectomy was genuinely the right answer. My job isn't to validate what a patient already believes, but what their situation calls for."
Sarath Palakodeti DO FACS FAACS
Printable Decision Guide
Bring This With You
A condensed version of this guide including the questions to ask your surgeon and space to write your own notes is available as a printable PDF.
Schedule a Consultation
The right decision is the one made with complete information
Dr. Palakodeti's practice serves patients across the South Central Kentucky and Northern Tennessee region. Newly diagnosed patients are prioritized for prompt scheduling.
484 Golden Autumn Way suite 201, Bowling Green, KY, USA
Hours
Today | Closed |
Copyright © 2026 Dr. Sarath Palakodeti - All Rights Reserved.